Lab-Grown Islet Cells: What the Research Shows About a Potential Type 1 Treatment

Scientists can now grow insulin-producing islet cells in the laboratory and transplant them into people with Type 1 diabetes. Here's what this emerging research means and what questions remain.

Community video — lay discussion, not peer-reviewed research

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cureresearchclinical trial

Key takeaways

Islet cells are clusters in the pancreas containing beta cells, which normally produce insulin in response to food and drink
In Type 1 diabetes, the immune system destroys beta cells, stopping insulin production
Researchers have developed methods to grow islet cells in laboratories and transplant them back into patients
Lab-grown islet cells show promise in monitoring glucose and secreting insulin after transplantation
This research is still developing; widespread availability is not expected in the near term

Understanding Islet Cells and Type 1 Diabetes

Islet cells are small clusters of specialized cells found throughout the pancreas. Within these clusters are beta cells, which have one critical job: they sense when blood sugar rises after eating or drinking and respond by releasing insulin to bring glucose levels back into range.

In Type 1 diabetes, the immune system mistakenly attacks and destroys these beta cells. Without them, the pancreas can no longer produce insulin on its own, which is why people with Type 1 require insulin therapy.

Growing Islet Cells in the Laboratory

Researchers have now developed techniques to grow islet cells outside the body in laboratory settings. These lab-grown cells can then be transplanted back into people with Type 1 diabetes.

After transplantation, these cells can function like natural islet cells—monitoring blood glucose levels and releasing insulin as needed. This approach represents a different treatment pathway from current insulin therapies, though research is still ongoing to optimize the process and improve outcomes.

Where This Research Stands

Lab-grown islet cell transplantation remains an emerging area of research with significant promise. However, it is not yet a widely available treatment option.

Scientists and clinicians continue to study this approach to understand its full potential, address technical challenges, and determine how it might fit into the broader landscape of Type 1 diabetes care. As with any developing therapy, more evidence and real-world experience are needed before it becomes accessible to most people living with Type 1.

Evidence label

Source: YouTube community video. Evidence type: Community video — lay discussion, not peer-reviewed research. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.